Memorial Fund for Ivan Lobov

Ivan Lobov (02/29/1972 – 04/09/2020), Regeneron Pharmaceutical Ophthalmology Senior Staff Scientist (2011 -2017), Biocad Project Leader (2018), and Palmira Biopharma Biopharma founder and Chief Scientific Officer, died on April 9, 2020 after a prolonged coma and partial consciousness, following a traumatic accident in November 2019.
Ivan was born in Saint Petersburg, Russia on February 29, 1972. With restless energy and curiosity for life, Ivan Lobov
graduated with MS in Biology from Saint Petersburg University Russia and was awarded a Philosophy Doctorate in Biology at the Institute of Cytology, Russian Academy of Sciences in Saint Petersburg for his work on chromatin structure and gene expression. In 2000, Ivan Lobov
moved to New York for postdoctoral training at the prestigious Skirball Institute for Advanced Medicine and subsequently followed his advisor Cincinnati Children’s Research Hospital, before joining Regeneron Pharmaceutical in 2011. In the course of his prominent carrier Ivan authored several seminal publications and patents in ophthalmology and vasculogenesis, including a contribution to the Regeneron Eylea blockbuster for macular degeneration.
We, Ivan's friends and colleagues, will remember Ivan with tenderness and joy always.

During the course of his treatment since the accident November 2019, his friends have been helping his family to raise money to cover Ivan’s medical expenses.

For more information.
https://www.facebook.com/groups/831094550743308


About me:
I am an employee at Regeneron Pharmaceuticals. Ivan was my supervisor for 10 years. He trained me on retinal developmental biology and the oxygen induced retinopathy model in mice. I was also very fortunate to be able to collaborate with him on a paper last year.

The potassium channel Kcne3 is a VEGFA-inducible gene selectively expressed by vascular endothelial tip cells.

Deckelbaum RA, Lobov IB, Cheung E, Halasz G, Rajamani S, Lerner J, Tong C, Li Z, Boland P, Dominguez M, Hughes V, Yancopoulos GD, Murphy AJ, Thurston G, Cao J, Romano C, Gale NW.

Angiogenesis. 2019 Nov 21. doi: 10.1007/s10456-019-09696-8. [Epub ahead of print]

The Dll4/Notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flow.

Lobov IB, Cheung E, Wudali R, Cao J, Halasz G, Wei Y, Economides A, Lin HC, Papadopoulos N, Yancopoulos GD, Wiegand SJ.

Blood. 2011 Jun 16;117(24):6728-37. doi: 10.1182/blood-2010-08-302067. Epub 2011 Apr 15.

I currently in contact with Ivan's sister, Yulia Lobova. All funds will be transferred to her to pay off any remaining expenses.